Furthermore, the application of HMSNs-PEI-BTZ-p53 led to the restoration of p53 expression and the reactivation of the p53 signaling pathway, which collectively contributed to a pronounced synergistic effect in tumor suppression and improved the therapeutic efficacy of BTZ. The gene discussed is TP53; the disease is neoplasm.